Weight-loss drug users turn to plastic surgery to address loose skin, ethical questions arise

Q: How long will it take to read this news story?

The story "Weight-loss drug users turn to plastic surgery to address loose skin, ethical questions arise" has 1382 words across 47 sentences, which will take approximately 6 - 12 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Weight-loss drug users turn to plastic surgery to address loose skin, ethical questions arise" was covered 4 days ago by Business Mirror, a news publisher based in Philippines.

Q: How trustworthy is 'Business Mirror' news outlet?

Business Mirror is a fully independent (privately-owned) news outlet established in 2005 that covers mostly business and startups news. The outlet is headquartered in Philippines and publishes an average of 33 news stories per day. It's most recent story was published 16 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21417033</li><li>URL: https://beamstart.com/news/weight-loss-drug-users-turn-17196793788884</li></ul>

Business Mirror Logo Business Mirror 4d ago

Weight-loss drug users turn to plastic surgery to address loose skin, ethical questions arise - Business Mirror

Quick Summary:

Some of the regained weight may end up at other parts of the body, at least in the case of patients who also get liposuction, researchers showed in a 2011 study. Once fat cells are removed from one area, the body looks to store excess calories as fat elsewhere, so liposuction on thighs could lead to more fatty arms.

And the number of weight-loss drug users is only expected to rise as more options become available.Eli Lilly & Co.’s Zepbound, for example, only launched in December, so many of these patients may not have been captured in the ASPS report.

As more of the estimated millions of people taking GLP-1 weight-loss shots from Eli Lilly and Novo Nordisk A/S or copycat drugs sold by companies like Hims & Hers Health begin to consider plastic surgery, doctors are now faced with ethical questions.